Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Flexi Cap Fund median (46 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 25 Sep 2008 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | JM Flexicap Fund |
|---|---|
| 25 Sep 2008 | ₹100.00 |
| 24 Mar 2010 | ₹142.35 |
| 20 Sep 2011 | ₹120.03 |
| 18 Mar 2013 | ₹127.34 |
| 13 Sep 2014 | ₹204.07 |
| 11 Mar 2016 | ₹193.42 |
| 07 Sep 2017 | ₹313.85 |
| 06 Mar 2019 | ₹302.56 |
| 01 Sep 2020 | ₹321.32 |
| 28 Feb 2022 | ₹503.45 |
| 26 Aug 2023 | ₹667.31 |
| 21 Feb 2025 | ₹912.26 |
| 20 Aug 2026 | ₹1022.41 |
| Metric | JM Financial · Regular NAV ₹101.22 Very High risk ★★☆☆☆ | Category median Flexi Cap Fund · 46 funds |
|---|---|---|
| +3.06% | +3.25% | |
| +15.44% | +13.01% | |
| +16.42% | +11.30% | |
| +15.61% | +12.76% | |
| +13.87% | +12.77% | |
| +14.30% | — | |
| +14.85% | +14.91% | |
| +15.11% | +14.39% | |
| +14.53% | +13.95% | |
| Risk | ||
| 15.79% | 14.17% | |
| 0.57 | 0.45 | |
| 0.75 | 0.61 | |
| -42.41% | -31.26% | |
| Nifty 500 | — | |
| +2.83% | +1.10% | |
| 1.04 | 0.97 | |
| 113.8% | 100.1% | |
| 104.7% | 93.5% | |
| 2.28% | 2.15% | |
| ₹5,032Cr | ₹4,325Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 21% | 33% | |
| Ruchi Fozdar | — | |
| 25 Sep 2008 | — | |
| 85 | — | |
| 29.5% | — | |
| 1.4% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.